BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24851952)

  • 1. Warty intralymphatic histiocytosis successfully treated with topical tacrolimus.
    Tsujiwaki M; Hata H; Miyauchi T; Homma E; Aoyagi S; Shimizu H
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2267-9. PubMed ID: 24851952
    [No Abstract]   [Full Text] [Related]  

  • 2. Intralymphatic Histiocytosis: A case report and review of literature.
    Barba E; Colato C; Girolomoni G
    J Cutan Pathol; 2015 Sep; 42(9):593-9. PubMed ID: 26375955
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocytoma cutis treated with topical tacrolimus.
    El-Dars LD; Statham BN; Blackford S; Williams N
    Clin Exp Dermatol; 2005 May; 30(3):305-7. PubMed ID: 15807704
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reticular erythematous mucinosis: partial response to treatment with topical tacrolimus].
    Suárez-Amor O; Pérez-Bustillo A; González-Morán MA; Ramírez-Santos A; Rodríguez-Prieto MA
    Actas Dermosifiliogr; 2010; 101(1):105-6. PubMed ID: 20109408
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythematous patch overlying a swollen knee--quiz case. Intralymphatic histiocytosis.
    Chiu YE; Maloney JE; Bengana C
    Arch Dermatol; 2010 Sep; 146(9):1037-42. PubMed ID: 20855708
    [No Abstract]   [Full Text] [Related]  

  • 6. Upper facial swelling: an uncommon manifestation of intralymphatic histiocytosis.
    Wang Y; Yang H; Tu P
    Eur J Dermatol; 2012; 22(6):814-5. PubMed ID: 23397608
    [No Abstract]   [Full Text] [Related]  

  • 7. The expanding role of topical tacrolimus in dermatology.
    Evans AV
    Clin Exp Dermatol; 2005 Mar; 30(2):111-5. PubMed ID: 15725232
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of infliximab for intralymphatic histiocytosis with rheumatoid arthritis.
    Sakaguchi M; Nagai H; Tsuji G; Morinobu A; Kumagai S; Nishigori C
    Arch Dermatol; 2011 Jan; 147(1):131-3. PubMed ID: 21242414
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythematous indurated plaque on the right upper limb. Intralymphatic histiocytosis (IH) associated with orthopedic metal implant.
    de Unamuno Bustos B; García Rabasco A; Ballester Sánchez R; Martínez Aparicio A; Alegre de Miquel V
    Int J Dermatol; 2013 May; 52(5):547-9. PubMed ID: 23590369
    [No Abstract]   [Full Text] [Related]  

  • 10. Penile terra firma-forme dermatosis in a child: ultrastructural observation and topical ethacridine lactate and tacrolimus treatment.
    Chen HS; Li FG; Zhu Y; Wang T; Fan YM
    Eur J Dermatol; 2019 Apr; 29(2):222-224. PubMed ID: 30973333
    [No Abstract]   [Full Text] [Related]  

  • 11. Intralymphatic histiocytosis: cutaneous nodules and metal implants.
    Rossari S; Scatena C; Gori A; Grazzini M; Corciova S; Scarfì F; Lotti T; Massi D; de Giorgi V
    J Cutan Pathol; 2011 Jun; 38(6):534-5. PubMed ID: 21375562
    [No Abstract]   [Full Text] [Related]  

  • 12. Intralymphatic histiocytosis. A clinicopathologic study of 16 cases.
    Requena L; El-Shabrawi-Caelen L; Walsh SN; Segura S; Ziemer M; Hurt MA; Sangüeza OP; Kutzner H
    Am J Dermatopathol; 2009 Apr; 31(2):140-51. PubMed ID: 19318799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lichenoid type of cutaneous sarcoidosis: great response to topical tacrolimus.
    Vano-Galvan S; Fernandez-Guarino M; Carmona LP; Harto A; Carrillo R; Jaén P
    Eur J Dermatol; 2008; 18(1):89-90. PubMed ID: 18086604
    [No Abstract]   [Full Text] [Related]  

  • 14. Differentiating Intralymphatic Histiocytosis, Intravascular Histiocytosis, and Subtypes of Reactive Angioendotheliomatosis: Review of Clinical and Histologic Features of All Cases Reported to Date.
    Mazloom SE; Stallings A; Kyei A
    Am J Dermatopathol; 2017 Jan; 39(1):33-39. PubMed ID: 28027079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential new indications of topical calcineurin inhibitors.
    Luger T; Paul C
    Dermatology; 2007; 215 Suppl 1():45-54. PubMed ID: 18174692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive intermediate cell histiocytosis successfully treated by 2-chlorodeoxyadenosine.
    Randrianasolo MP; Beylot-Barry M; Vergier B; Cipriano G; Jegou-Penouil MH; Doutre MS
    J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1153-6. PubMed ID: 18384558
    [No Abstract]   [Full Text] [Related]  

  • 17. [Topical tacrolimus and resistant skin lesions of dermatomyositis].
    Peyrot I; Sparsa A; Loustaud-Ratti V; Liozon E; Vidal E; Bonnetblanc JM; Bedane C
    Rev Med Interne; 2006 Oct; 27(10):730-5. PubMed ID: 16987569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indeterminate cell histiocytosis treated successfully with 2-chlorodeoxyadenosine.
    Daoud MS; Dahl PR; Dicken CH; Phyliky RL
    Cutis; 1997 Jan; 59(1):27-31; quiz 32. PubMed ID: 9013068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indeterminate cell histiocytosis in a pediatric patient: successful treatment with thalidomide.
    Tóth B; Katona M; Hársing J; Szepesi A; Kárpáti S
    Pathol Oncol Res; 2012 Apr; 18(2):535-8. PubMed ID: 21688087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pimecrolimus (SDZ ASM 981). Current state of research].
    Dissemond J; Goos M; Wagner SN
    Dtsch Med Wochenschr; 2002 May; 127(22):1199-203. PubMed ID: 12035117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.